Roles of hepatic progenitor cells activation, ductular reaction proliferation and notch signaling in morbid obesity

Hepato-Gastroenterology

Volumn 59, Issue 118, 2012, Pages 1921-1927

  Liew, Phui Ly ^a,b   Wang, Weu ^b   Lee, Yi Chih ^c   Huang, Ming Te ^a   Lee, Wei Jei ^d  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHING YUN UNIVERSITY   (Taiwan)

^d MIN SHENG GENERAL HOSPITAL   (Taiwan)

Author keywords

Ductular reaction; Hepatic progenitor cells; Liver disease; Morbid obesity; Notch signaling

Indexed keywords

CD34 ANTIGEN; CYTOKERATIN 7; HEMOGLOBIN A1C; KI 67 ANTIGEN; NOTCH RECEPTOR; PROTEIN P21;

ADULT; ARTICLE; BODY MASS; CELL ACTIVATION; CELL COUNT; CELL EXPANSION; CELL PROLIFERATION; CLINICAL ARTICLE; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; KUPFFER CELL; LIVER CELL; LIVER FUNCTION TEST; MALE; MORBID OBESITY; MORPHOLOGY; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; STEM CELL;

ADOLESCENT; ADULT; BILE DUCTS, INTRAHEPATIC; BIOLOGICAL MARKERS; BIOPSY; CASE-CONTROL STUDIES; CELL CYCLE CHECKPOINTS; CELL PROLIFERATION; CHI-SQUARE DISTRIBUTION; FATTY LIVER; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KUPFFER CELLS; LINEAR MODELS; LIVER; LIVER FUNCTION TESTS; MALE; OBESITY, MORBID; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; STEM CELLS; TAIWAN; YOUNG ADULT;

EID: 84867702988     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge10861     Document Type: Article

References (36)

1. Alison MR, Islam S, Lim S: Stem cells in liver regeneration, fibrosis and cancer: the good, the bad and the ugly. J Pathol 2009; 217:282-298.
2. Zhang L, Theise N, Chua M, et al.: The stem cell niche of human livers: symmetry between development and regeneration. Hepatology 2008; 48:1598-1607.
3. Roskams TA, Theise ND, Balabaud C, et al.: Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reactions in human livers. Hepatology 2004; 39:1739-1745. (Pubitemid 38702678)
4. Eleazar JA, Memeo L, Jhang JS, et al.: Progenitor cell expansion: an important source of hepatocytes regeneration in chronic hepatitis. J Hepatol 2004; 41:983-991. (Pubitemid 39575666)
5. Zhou H, Rogler LE, Teperman L, et al.: Identification of hepatocytic and bile ductular cell lineages and candidate stem cells in bipolar ductular reactions in cirrhotic human liver. Hepatology 2007; 45:716-724. (Pubitemid 46450623)
6. Bateman AC, Hübscher SG: Cytokeratin expression as an aid to diagnosis in medical liver biopsies. Histopathology 2010; 56:415-425.
7. Tan J, Hytiroglou P, Wieczorek R, et al.: Immunohistochemical evidence for hepatic progenitor cells in liver diseases. Liver 2002; 22:365-373. (Pubitemid 35331396)
8. Wang X, Willenbring H, Akkari Y, et al.: Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature 2003; 422:897-901. (Pubitemid 36520042)
9. Vassilopoulos G, Wang PR, Russel DW: Transplanted bone marrow regenerates liver by cell fusion. Nature 2003; 422:901-904. (Pubitemid 36520043)
10. Weiss TS, Lichtenauer M, Kirchner S, et al.: Hepatic progenitor cells from adult human livers for cell transplantation. Gut 2008; 57:1129-1138.
11. Clouston AD, Powell EE, Walsh MJ, et al.: Fibrosis correlates with a ductular reaction in hepatitis C: roles of impaired replication, progenitor cells and steatosis. Hepatology 2005; 41:809-818. (Pubitemid 40462943)
12. Roskams T, Yang SQ, Koteish A, et al.: Oxidative stress and oval cell accumulation in mice and humans with alcoholic and non-alcoholic fatty liver disease. Am J Pathol 2003; 163:1301-1311. (Pubitemid 37175079)
13. Libbrecht L, Desmet V, Van Damme B, et al.: Deep intralobular extension of human hepatic 'progenitor cells' correlates with parenchymal inflammation in chronic viral hepatitis: can 'progenitor cells' migrate? J Pathol 2000; 192:373-378.
14. Lowes KN, Brennan BA, Yeoh GC, et al.: Oval cell numbers in human chronic liver diseases are directly related to disease severity. Am J Pathol 1999; 154:537-541. (Pubitemid 29094103)
15. Fotiadu A, Tzioufa V, Vrettou E, et al.: Progenitor cell activation in chronic viral hepatitis. Liver Int 2004; 24:268-274. (Pubitemid 38930867)
16. Mateo MS, Saez AI, Sanchez-Beato M, et al.: Expression of p21WAF1/CIP1 in fetal and adult tissues: simultaneous analysis with Ki67 and p53. J Clin Pathol 1997; 50:645-653. (Pubitemid 27396066)
17. Crary GS, Albrecht JH: Expression of cyclin-dependent kinase inhibitor p21 in human liver. Hepatology 1998; 28:738-743. (Pubitemid 28405423)
18. Sasaki M, Ikeda H, Yamaguchi J, et al.: Bile ductular cells undergoing cellular senescence increase in chronic liver diseases along with fibrous progression. Am J Clin Pathol 2010; 133:212-223.
19. Marshall A, Rushbrook S, Davies SE, et al.: Relation between hepatocyte G1 arrest, impaired hepatic regeneration, and fibrosis in chronic hepatitis C virus infection. Gastroenterology 2005; 128:33-42. (Pubitemid 40039956)
20. Kodama Y, Hijikata M, Kageyama R, et al.: The role of notch signaling in the development of intrahepatic bile ducts. Gastroenterology 2004; 127:1775-1786. (Pubitemid 39575856)
21. Nijjar SS, Crosby HA, Wallace L, et al.: Notch receptor expression in adult human liver: a possible role in bile duct formation and hepatic neovascularization. Hepatology 2001; 34:1184-1192. (Pubitemid 33096591)
22. Spee B, Carpino G, Schotanus BA, et al.: Characterization of the liver progenitor cell niche in liver diseases: potential involvement of Wnt and Notch signaling. Gut 2010; 59:247-257.
23. Gramantieri L, Giovannini C, Lanzi A, et al.: Aberrant Notch3 and Notch4 expression in human hepatocellular carcinoma. Liver Int. 2007; 27:997-1007. (Pubitemid 47261955)
24. Brunt EM, Janney CG, Di Bisceglie AM, et al.: Non-alcoholic steatohepatitis: A proposal for grading and staging histological lesions. Am J Gastroenterol 1999; 94:2467-2474. (Pubitemid 29420675)
25. Kleiner DE, Brunt EM, Van Natta M, et al.: Design and validation of a histological scoring system for non-alcoholic fatty liver disease. Hepatology 2005; 41:1313-1321. (Pubitemid 40770284)
26. Ishak K, Baptista A, Bianchi L, et al.: Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22:696-699.
27. Liew PL, Lee WJ, Lee YC, et al.: Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease. Obes Surg 2006; 16:1584-1593.
28. Richardson MM, Jonsson JR, Powell EE, et al.: Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction. Gastroenterology 2007; 133:80-90. (Pubitemid 47031146)
29. Yang S, Koteish A, Lin H, et al.: Oval cells compensate for damage and replicative senescence of mature hepatocytes in mice with fatty liver disease. Hepatology 2004; 39:403-411. (Pubitemid 38222181)
30. Valva P, De Matteo E, Galoppo M, et al.: Apoptosis markers in liver biopsy of nonalcoholic steatohepatitis in pediatric patients. Hum Pathol. 2008; 39:1816-1822.
31. Rakha EA, Adamson L, Bell E, et al.: Portal inflammation is associated with advanced histological changes in alcoholic and non-alcoholic fatty liver disease. J Clin Pathol 2010; 63:790-795.
32. Geisler F, Nagl F, Mazur PK, et al.: Liver-specific inactivation of Notch2, but not Notch1, compromises intrahepatic bile duct development in mice. Hepatology 2008; 48:607-616.
33. Flynn DM, Nijjar S, Hubscher SG, et al.: The role of Notch receptor expression in bile duct development and disease. J Pathol 2004; 204:55-64. (Pubitemid 39214482)
34. Fabris L, Cadamuro M, Guido M, et al.: Analysis of liver repair mechanisms in Alagille syndrome and biliary atresia reveals a role for notch signaling. Am J Pathol 2007; 171:641-653. (Pubitemid 47344696)
35. Nijjar SS, Wallace L, Crosby HA, et al.: Altered Notch ligand expression in human liver disease: further evidence for a role of the Notch signaling pathway in hepatic neovascularization and biliary ductular defects. Am J Pathol 2002; 160:1695-1703. (Pubitemid 34525649)
36. Gao J, Song Z, Chen Y, et al.: Deregulated expression of Notch receptors in human hepatocellular carcinoma. Dig Liver Dis 2008; 40:114-121.